Morgane Cheminant

2.0k total citations
31 papers, 480 citations indexed

About

Morgane Cheminant is a scholar working on Pathology and Forensic Medicine, Oncology and Immunology. According to data from OpenAlex, Morgane Cheminant has authored 31 papers receiving a total of 480 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pathology and Forensic Medicine, 10 papers in Oncology and 10 papers in Immunology. Recurrent topics in Morgane Cheminant's work include Lymphoma Diagnosis and Treatment (15 papers), T-cell and Retrovirus Studies (7 papers) and Chronic Lymphocytic Leukemia Research (6 papers). Morgane Cheminant is often cited by papers focused on Lymphoma Diagnosis and Treatment (15 papers), T-cell and Retrovirus Studies (7 papers) and Chronic Lymphocytic Leukemia Research (6 papers). Morgane Cheminant collaborates with scholars based in France, Belgium and Lebanon. Morgane Cheminant's co-authors include Michael P. LaValley, Alfred Mahr, Carla Maldini, Mathilde de Menthon, Olivier Hermine, Noémie Simon‐Tillaux, C. Bourgier, Éric Deutsch, Cyrus Chargari and Antonin Lévy and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Clinical Infectious Diseases.

In The Last Decade

Morgane Cheminant

26 papers receiving 475 citations

Peers

Countries citing papers authored by Morgane Cheminant

Since Specialization

Citations

This map shows the geographic impact of Morgane Cheminant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Morgane Cheminant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Morgane Cheminant more than expected).

Fields of papers citing papers by Morgane Cheminant

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Morgane Cheminant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Morgane Cheminant. The network helps show where Morgane Cheminant may publish in the future.

Co-authorship network of co-authors of Morgane Cheminant

This figure shows the co-authorship network connecting the top 25 collaborators of Morgane Cheminant. A scholar is included among the top collaborators of Morgane Cheminant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Morgane Cheminant. Morgane Cheminant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Outcome of patients with mantle cell lymphoma after failure of anti-CD19 CAR T-cell therapy: a DESCAR-T study by LYSA Group 2025 ·Blood Advances ·M. Aymard, Morgane Cheminant, Roch Houot, (unknown), Elodie Gat, Catherine Thiéblemont, Laure Ricard, Louise Roulin, Krimo Bouabdallah, Violaine Safar, Stéphanie Guidez, (unknown), (unknown), Loïc Ysebaert, Olivier Hermine, Benoît Tessoulin, Charles Herbaux, Steven Le Gouill, Clémentine Sarkozy	0
2	High efficacy of CD19 CAR T cells in patients with transformed Waldenström macroglobulinemia 2024 ·Blood ·Éric Durot, Damien Roos‐Weil, Adrien Chauchet, Justine Decroocq, Roberta Di Blasi, Thomas Gastinne, (unknown), Morgane Cheminant, (unknown), Stéphanie Guidez, François‐Xavier Gros, Emmanuel Bachy, (unknown), Pascale Cony‐Makhoul, Steven P. Treon, Alain Delmer, Ran Reshef, Steven Le Gouill, Jorge J. Castillo, Roch Houot	3
3	Outcome of Patients with Mantle Cell Lymphoma after Failure of Anti-CD19 CAR T-Cell Therapy: A Descar-T Study By Lysa Group 2024 ·Blood ·M. Aymard, Morgane Cheminant, Roch Houot, (unknown), Elodie Gat, Catherine Thiéblemont, Laure Ricard, Louise Roulin, Krimo Bouabdallah, Violaine Safar, Stéphanie Guidez, (unknown), Gabriel Brisou, Loïc Ysebaert, Olivier Hermine, Benoît Tessoulin, Charles Herbaux, Steven Le Gouill, Clémentine Sarkozy	0
4	KILT: A RANDOMIZED NON‐COMPARATIVE PHASE II LYSA STUDY OF LACUTAMAB WITH GEMOX VERSUS GEMOX IN RELAPSED/REFRACTORY PERIPHERAL T‐CELL LYMPHOMA 2023 ·Hematological Oncology ·Morgane Cheminant, Sylvain Carras, Julie Bruneau, François Lemonnier, Emmanuel Bachy, Charles Herbaux, Pierre Feugier, Nicolas Daguindau, Thomas Gastinne, (unknown), (unknown), Borhane Slama, (unknown), Franck Morschhauser, Olivier Tournilhac, Philippe Gaulard, Vahid Asnafi, Nicolás Ortonne, Gandhi Damaj, Olivier Hermine	0
5	Very long-term follow-up of rituximab maintenance in young patients with mantle cell lymphoma included in the LYMA trial, a LYSA study. 2023 ·Journal of Clinical Oncology ·Clémentine Sarkozy, Catherine Thieblemont, Lucie Obéric, Philippe Moreau, Krimo Bouabdallah, Gandhi Damaj, Thomas Gastinne, Olivier Casasnovas, Corinne Haïoun, Roch Houot, Éric Van Den Neste, Morgane Cheminant, Hervé Ghesquières, Vincent Ribrag, Franck Morschhauser, Mary Callanan, Rémy Gressin, Olivier Hermine, Steven Le Gouill, Fabrice Jardin	1
6	VERY LONG‐TERM FOLLOW‐UP OF RITUXIMAB MAINTENANCE IN YOUNG PATIENTS WITH MANTLE CELL LYMPHOMA INCLUDED IN THE LYMA TRIAL, A LYSA STUDY. 2023 ·Hematological Oncology ·Clémentine Sarkozy, Catherine Thiéblemont, Lucie Obéric, Philippe Moreau, Krimo Bouabdallah, Gandhi Damaj, (unknown), Vincent Ribrag, Olivier Casasnovas, Corinne Haïoun, Roch Houot, Fabrice Jardin, Éric Van Den Neste, Morgane Cheminant, Franck Morschhauser, (unknown), Hervé Ghesquières, Rémy Gressin, Olivier Hermine, Steven Le Gouill	0
7	Tumor Microenvironment and Immunotherapy-Based Approaches in Mantle Cell Lymphoma 2022 ·Cancers ·Khalil Saleh, Morgane Cheminant, David Chiron, Barbara Burroni, Vincent Ribrag, Clémentine Sarkozy	15
8	Curative allogeneic hematopoietic stem cell transplantation following reduced toxicity conditioning in adults with primary immunodeficiency 2022 ·Bone Marrow Transplantation ·Ambroise Marçais, Nizar Mahlaoui, Bénédicte Neven, Fanny Lanternier, Émilie Catherinot, Hélène Salvator, Morgane Cheminant, (unknown), Vahid Asnafi, Peter Van Endert, Louis‐Jean Couderc, Olivier Lortholary, Capucine Pïcard, Despina Moshous, Olivier Hermine, Alain Fischer, Felipe Suárez	4
9	Daratumumab, an original approach for treating multi-refractory autoimmune cytopenia 2021 ·Haematologica ·Étienne Crickx, Sylvain Audia, A. Robbins, David Boutboul, Thibault Comont, Morgane Cheminant, Éric Oksenhendler, Bertrand Godeau, Marc Michel, Matthieu Mahévas	29
10	Loss of interleukin-10 activates innate immunity to eradicate adult T-cell leukemia-initiating cells 2021 ·Haematologica ·Hiba El Hajj, Rita Hleihel, Marwan El Sabban, Julie Bruneau, Ghazi Zaatari, Morgane Cheminant, Ambroise Marçais, (unknown), Hideki Hasegawa, William W. Hall, Hugues de Thé, Olivier Hermine, Ali Bazarbachi	11
11	Targeted deep sequencing reveals clonal and subclonal mutational signatures in Adult T-cell leukemia/lymphoma and defines an unfavorable indolent subtype 2020 ·Leukemia ·Ambroise Marçais, Ludovic Lhermitte, Maria Artesi, Cécile Laurent, Keith Durkin, Vincent Hahaut, Nicolas Rosewick, Felipe Suárez, David Sibon, Morgane Cheminant, Véronique Avettand-Fènoël, Julie Bruneau, Michel Georges, Claudine Pique, Anne Van den Broeke, Vahid Asnafi, Olivier Hermine	21
12	Arsenic trioxide (As2O3) as a maintenance therapy for adult T cell leukemia/lymphoma 2020 ·Retrovirology ·Ambroise Marçais, Lucy Cook, Aviva Witkover, Vahid Asnafi, Véronique Avettand-Fènoël, Richard Delarue, Morgane Cheminant, David Sibon, Laurent Frenzel, Hugues de Thé, Charles R. M. Bangham, Ali Bazarbachi, Olivier Hermine, Felipe Suárez	20
13	Novel Treatments of Adult T Cell Leukemia Lymphoma 2020 ·Frontiers in Microbiology ·Hiba El Hajj, Kunihiro Tsukasaki, Morgane Cheminant, Ali Bazarbachi, Toshiki Watanabe, Olivier Hermine	32
14	A Transmissible Rash of Palms and Soles in a 58-Year-Old Man 2017 ·Clinical Infectious Diseases ·Romain Guéry, Claire Aguilar, Isabelle Schuffenecker, Marianne Leruez‐Ville, Morgane Cheminant, Fanny Lanternier, Marc Lecuit, Olivier Lortholary	1
15	Minimal residual disease monitoring by 8-color flow cytometry in mantle cell lymphoma: an EU-MCL and LYSA study 2015 ·Haematologica ·Morgane Cheminant, Coralie Derrieux, Aurore Touzart, Stephanie L. Schmit, A Grenier, (unknown), Marie‐Hélène Delfau‐Larue, Ludovic Lhermitte, Catherine Thiéblemont, Vincent Ribrag, S. Chèze, Laurence Sanhès, (unknown), (unknown), Richard Delarue, Eva Hoster, (unknown), Vahid Asnafi, Olivier Hermine, Elizabeth Macintyre	43
16	Prognosis and outcome of stem cell transplantation for mantle cell lymphoma 2015 ·Expert Review of Hematology ·Morgane Cheminant, Stephen Robinson, Vincent Ribrag, Steven Le Gouill, Felipe Suárez, Richard Delarue, Olivier Hermine	2
17	Prise en charge diagnostique et thérapeutique d’un patient porteur d’une thrombocytose 2013 ·La Revue de Médecine Interne ·Morgane Cheminant, Richard Delarue	2
18	Plasma uric acid response to rasburicase: early marker for acute kidney injury in tumor lysis syndrome? 2013 ·Leukemia & lymphoma ·Emmanuel Canet, Morgane Cheminant, Lara Zafrani, Catherine Thiéblemont, Lionel Galicier, Étienne Lengliné, David Schnell, Danielle Reuter, Michaël Darmon, Benoı̂t Schlemmer, Élie Azoulay	11
19	Radiation therapy and immunotherapy: Implications for a combined cancer treatment 2012 ·Critical Reviews in Oncology/Hematology ·Antonin Lévy, Cyrus Chargari, Morgane Cheminant, Noémie Simon‐Tillaux, C. Bourgier, Éric Deutsch	59
20	Relationships of HLA-B51 or B5 genotype with Behçet's disease clinical characteristics: systematic review and meta-analyses of observational studies 2012 ·Lara D. Veeken ·Carla Maldini, Michael P. LaValley, Morgane Cheminant, Mathilde de Menthon, Alfred Mahr	136

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact